News Briefs
- 4/7/2025
Xyzal teams up with 2025 Hall of Famer CC Sabathia
Xyzal is taking its allergy medication to the baseball field.
The brand recently teamed up with former New York Yankee and 2025 Hall of Famer CC Sabathia, to spotlight just how its products can help combat common allergy symptoms that include sneezing, itchy eyes and a runny nose among other symptoms.
Sabathia attended the Yankees vs Diamondbacks game on April 3, where he expressed his excitement for the upcoming season. He also was excitement about being honored alongside some of his idols at the 2025 Hall of Fame ceremony, his retirement from the sport and how Xyzal has helped with any allergy symptoms he suffered from throughout the spring.
Xyzal is available for purchase over the counter at major retailers nationwide.
- 4/4/2025
Byoma protects skin with Ultralight Face Fluid SPF
Byoma combines UVA and UVB defense with a hydrating and soothing formula for the skin.
The brand's new Ultralight Face Fluid SPF contains its exclusive Cera-Sun Technology and is infused with such ingredients as hyaluronic acid, astaxanthin and ceramides for hydration, antioxidant protection and skin barrier health support.
Ideal for daily use, the sunscreen leaves behind a non-greasy finish and no white cast, the brand shared.
Retailing for $18.99 at Target and $19.99 at Ulta Beauty, Byoma’s new Ultralight Face Fluid SPF is now available for purchase.
- 4/2/2025
Zyrtec updates packaging
Zyrtec is showcasing a brand new look.
The company recently announced a packaging revamp that is made with 100% paper across all its product lines.
With a modern, flat-front package design, the company aims to communicate its product benefits and ingredient transparency with larger text that is easier to read.
In addition, the revamp will utilize bright colors including red, orange and yellow, the brand noted.
- 4/2/2025
Ashley Graham named the face of Revlon’s ColorSilk
Ashley Graham is taking on a new role as part of her global brand ambassadorship with Revlon.
The beauty brand announced that the model has been named the new face of the ColorSilk line, which recently also revamped its formula.
ColorSilk, an ammonia-free hair dye line, is now formulated with a Bond Repair Complex that helps deliver vibrant and long-lasting color, as well as gray coverage, the company shared.
In this new role, Graham will showcase how ColorSilk helps in maintaining her color and hair health.
Retailing for $4.97, Revlon’s ColorSilk is now available for purchase at Walmart.
- 3/31/2025
Listerine unveils Clinical Solutions Sensitive Teeth
Listerine is expanding its Clinical Solutions line with the latest mouthwash – Sensitive Teeth. This product line is designed to combat and help prevent early gum disease, tooth decay, persistent bad breath and tooth sensitivity.
New Listerine Clinical Solutions Sensitive Teeth is uniquely designed to reverse tooth sensitivity and provide 24-hour relief with continual use while killing 99.9% of bad breath germs, the company said.
With this new mouthwash, sensitive teeth sufferers can now savor hot and cold drinks, sweets and acidic foods they previously had to avoid, the company said.
Listerine Clinical Solutions is available for $8.87-$11.97 at major retailers including Walmart, Amazon, Walgreens, Target & CVS.
- 3/28/2025
Walgreens agrees to settle allegations of overbilling Medicaid programs
Walgreens has agreed to pay over $2.8 million to resolve allegations that it violated the federal, Massachusetts and Georgia False Claims Acts by submitting inflated prices for certain generic medications to the Massachusetts and Georgia Medicaid programs.
The Massachusetts Medicaid program and the Georgia Medicaid program are jointly funded and administered federal and state programs that cover medical costs, including medication costs, for persons with limited income. The MassHealth and the Georgia Medicaid program reimburse Walgreens’ pharmacies for dispensing generic medications to beneficiaries using the lowest of four reporting price points. One of the four price points is each pharmacy’s “usual and customary price,” which is generally the amount of money the pharmacy is willing to accept for a medication on that date of service.
The United States, Massachusetts and Georgia allege that, between 2008 and 2023, Walgreens’ pharmacies submitted a higher usual and customary price to the MassHealth and Georgia Medicaid programs for certain generic medications at certain times. By failing to report the correct usual and customary price, Walgreens’ pharmacies allegedly caused the MassHealth and Georgia Medicaid programs to pay more for these generic medications than they should have.
The settlement resolves, in part, claims brought by a whistleblower under the qui tam provisions of the federal, Massachusetts, and Georgia False Claims Acts. Under all three False Claims Acts, private parties may sue on behalf of the government and receive a share of a recovery.